BeStock  
Stocks › Biotechnology › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3472Biotechnology
$7.02 −$0.13 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.02 0.00%
Open$7.01
Prev close$7.15
Day range$6.88 – $7.36
Volume1.26M
Market cap$615.00M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$77.53M-69.0% YoY
Net profit-$73.60M-74.3% YoY
Diluted EPS-$0.73-49.0% YoY
Free cash flow-$48.01M-39.1% YoY
Operating cash flow-$47.11M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-33.6MDec '24$-30.4MMar '25$-43.8MJun '25$-42.2MSep '25$-46.1MDec '25$-53.1MMar '26$-63.2MJun '26$-73.6MSep '26

Diluted EPS by quarter

-0.40Dec '24-0.36Mar '25-0.51Jun '25-0.49Sep '25-0.51Dec '25-0.52Mar '26-0.61Jun '26-0.73Sep '26

Free cash flow by quarter

$-26.3MDec '24$-44.0MMar '25$-29.9MJun '25$-34.5MSep '25$-38.3MDec '25$-46.0MMar '26$-46.1MJun '26$-48.0MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-69.8%
Return on assets-59.5%
Return on invested capital-74.0%
Current ratio6.12
Liabilities / assets16.4%
Cash & investments$413.77M
Total debt$3.00M
Net cash (debt)$410.77M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $77.53M $67.18M $57.99M $178.70M $50.08M
Selling and Admin Expenses $9.93M $9.39M $8.75M $21.00M $6.86M
-General & Admin Expense $9.93M $9.39M $8.75M $21.00M $6.86M
Research & Development $67.60M $57.79M $49.23M $157.70M $43.22M
Operating Profit -$77.53M -$67.18M -$57.99M -$178.70M -$50.08M
Net Non-Operating Interest Income (Expense) $4.05M $4.51M $4.78M $16.22M $4.01M
Non-Operating Interest Income $4.05M $4.51M $4.78M $16.22M $4.01M
Other Income (Expense) -$128,000.00 -$528,000.00 $121,000.00 $23,000.00 $13,000.00
Other Non-Operating Income (Expenses) -$128,000.00 -$528,000.00 $121,000.00 $23,000.00 $13,000.00
Pretax Profit -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Net Profit -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Profit from Continuing Operations -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Net Income to Parent Company -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Net Income to Common Stockholders -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Basic EPS -$0.73 -$0.61 -$0.52 -$1.87 -$0.51
Diluted EPS -$0.73 -$0.61 -$0.52 -$1.87 -$0.51

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $441.07M $486.58M $530.65M $533.43M $533.43M
Total Current Assets $423.43M $469.88M $513.23M $515.45M $515.45M
Cash and Cash Equivalents & Short-Term Investments $413.77M $461.07M $505.35M $505.44M $505.44M
-Cash and Cash Equivalents $47.52M $48.60M $52.55M $48.30M $48.30M
-Short Term Investments $366.25M $412.47M $452.80M $457.14M $457.14M
Receivables $3.37M $3.17M $3.35M $4.06M $4.06M
-Accrued Interest Receivable $3.11M $2.85M $3.32M $3.14M $3.14M
-Taxes Receivable $269,000.00 $321,000.00 $30,000.00 $919,000.00 $919,000.00
Prepaid Assets $6.05M $5.43M $3.30M $4.37M $4.37M
Other Current Assets $235,000.00 $206,000.00 $1.23M $1.59M $1.59M
Total Non-Current Assets $17.65M $16.70M $17.42M $17.98M $17.98M
Net PPE $2.00M $1.02M $1.28M $1.42M $1.42M
-Gross PPE $2.00M $1.02M $1.28M $1.42M $1.42M
Non-Current Prepaid Assets $14.92M $14.90M $15.30M $15.67M $15.67M
Goodwill and Other Intangible Assets $729,000.00 – – – –
-Other Intangible Assets $729,000.00 – – – –
Total Liabilities $72.23M $56.01M $50.17M $54.87M $54.87M
Total Current Liabilities $69.23M $53.01M $47.17M $51.80M $51.80M
Payables $1.21M $1.67M $3.72M $9.25M $9.25M
-Accounts Payable $1.21M $1.67M $3.72M $9.25M $9.25M
Current Accrued Expenses $60.86M $46.21M $40.29M $33.17M $33.17M
Short-Term Debt and Capital Lease Obligation $356,000.00 $660,000.00 $956,000.00 $1.12M $1.12M
-Current Capital Lease Obligation $356,000.00 $660,000.00 $956,000.00 $1.12M $1.12M
Total Non-Current Liabilities $3.00M $3.00M $3.00M $3.07M $3.07M
Long Term Debt and Capital Lease Obligation $3.00M $3.00M $3.00M $3.07M $3.07M
-Long Term Debt $3.00M $3.00M $3.00M $3.00M $3.00M
-Long Term Capital Lease Obligation $0.00 $0.00 $0.00 $69,000.00 $69,000.00
Total Equity $368.84M $430.56M $480.48M $478.56M $478.56M
Stockholders' Equity $368.84M $430.56M $480.48M $478.56M $478.56M
Capital Stock $8,000.00 $8,000.00 $8,000.00 $8,000.00 $8,000.00
-Common Stock $8,000.00 $8,000.00 $8,000.00 $8,000.00 $8,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.16B $1.15B $1.13B $1.08B $1.08B
Retained Earnings -$787.45M -$713.85M -$650.65M -$597.56M -$597.56M
Gains/Losses Not Affecting Retained Earnings -$1.59M -$947,000.00 -$460,000.00 $621,000.00 $621,000.00
Other Non-Current Assets – $784,000.00 $838,000.00 $892,000.00 $892,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$47.11M -$45.90M -$45.99M -$146.72M -$38.33M
Net cash flow from continuing operations -$47.11M -$45.90M -$45.99M -$146.72M -$38.33M
Net Income from Continuing Operations -$73.60M -$63.20M -$53.09M -$162.45M -$46.06M
Depreciation & Depletion & Amortization $94,000.00 $102,000.00 $119,000.00 $490,000.00 $187,000.00
Other Non-Cash Items $298,000.00 $1.57M -$972,000.00 -$5.12M -$5.99M
Change in Working Capital $14.79M $5.22M -$2.19M $2.78M $4.14M
-Change in Prepaid Assets -$997,000.00 $75,000.00 $2.60M -$5.42M -$4.46M
-Change in Payables and Accrued Expense -$458,000.00 -$1.91M -$5.68M $4.60M $5.77M
-Change in Other Current Assets $52,000.00 -$668,000.00 -$100,000.00 -$6.15M -$496,000.00
-Change in Other Current Liabilities $16.19M $7.72M $991,000.00 $9.74M $3.32M
Net cash flow from investing $45.60M $40.84M $4.53M -$155.76M -$162.18M
Net Cash Flow from Continuing Investing Activities $45.60M $40.84M $4.53M -$155.76M -$162.18M
Net PPE Purchase and Sale -$850,000.00 – – $0.00 $0.00
Net Investment Purchase and Sale $46.45M $41.06M $4.53M -$155.76M -$162.18M
Financing Cash Flow $434,000.00 $1.11M $45.70M $211.30M $213.55M
Net Cash Flow from Continuing Financing Activities $434,000.00 $1.11M $45.70M $211.30M $213.55M
Net Issuance Payments Of Debt $0.00 – – $3.00M $0.00
Net Common Stock Issuance $0.00 $0.00 $41.92M $205.39M $205.39M
Proceeds from Stock Option Exercised $434,000.00 -$3.54M $8.43M $9.42M $8.16M
Ending Cash Balance $47.52M $48.60M $52.55M $48.30M $48.30M
Net Change in Cash -$1.08M -$3.95M $4.25M -$91.18M $13.04M
Beginning Cash Balance $48.60M $52.55M $48.30M $139.48M $35.26M
Free Cash Flow -$48.01M -$46.12M -$45.99M -$146.72M -$38.33M
Net Other Financing Charges – – -$4.64M -$6.51M $0.00

Discussion

No comments yet — be the first to weigh in on OLMA.

Sign in to join the discussion.

Scroll to Top